Valneva SE
Specialty vaccine company developing and commercializing vaccines for infectious diseases.
VLA | PA
Overview
Corporate Details
- ISIN(s):
- AT0000A10B99 (+3 more)
- LEI:
- 969500DIVIP5VKNW4948
- Country:
- France
- Address:
- 6 RUE ALAIN BOMBARD, 44800 SAINT-HERBLAIN
- Website:
- https://valneva.com/
- Sector:
- Manufacturing
Description
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-07-05 18:00 |
VALNEVA - Déclaration d’actions et de droits de vote - 30 juin 2022
|
French | 18.5 KB | ||
| 2022-06-30 18:05 |
Franchissement de seuil
|
French | 209.1 KB | ||
| 2022-06-30 18:04 |
Franchissement de seuils
|
French | 202.1 KB | ||
| 2022-06-27 08:30 |
Valneva SE Déclaration d’actions et de droits de vote - Situation intermédiaire…
|
French | 205.6 KB | ||
| 2022-06-27 08:30 |
Valneva SE Declaration of shares and voting rights - Interim status at June 22,…
|
English | 193.5 KB | ||
| 2022-06-24 18:00 |
Valneva reçoit une autorisation de mise sur le marché en Europe pour son vaccin…
|
French | 114.3 KB | ||
| 2022-06-24 18:00 |
Valneva Receives Marketing Authorization in Europe for Inactivated Whole-Virus …
|
English | 147.1 KB | ||
| 2022-06-24 07:05 |
Valneva Announces Successful Outcome of its AGM and Appointment of two New Supe…
|
English | 111.8 KB | ||
| 2022-06-24 07:05 |
Valneva annonce l’approbation des résolutions présentées à son Assemblée Généra…
|
French | 146.0 KB | ||
| 2022-06-23 17:45 |
Valneva and Pfizer Announce Closing of Equity Investment
|
English | 212.4 KB | ||
| 2022-06-23 17:45 |
Valneva et Pfizer annoncent la réalisation de l’opération de souscription au ca…
|
French | 242.8 KB | ||
| 2022-06-23 16:00 |
Valneva annonce la reprise des négociations de ses actions ordinaires sur Euron…
|
French | 99.8 KB | ||
| 2022-06-23 16:00 |
Valneva announces resumption of trading of its ordinary shares on Euronext Paris
|
English | 101.6 KB | ||
| 2022-06-23 15:16 |
Valneva reçoit un avis positif du CHMP pour une autorisation de mise sur le mar…
|
French | 151.9 KB | ||
| 2022-06-23 15:16 |
Valneva Receives Positive CHMP Opinion for Marketing Authorization of its Inact…
|
English | 148.9 KB |
Automate Your Workflow. Get a real-time feed of all Valneva SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Valneva SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Valneva SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-03-18 | N/A | Other | Buy | 44,222 | N/A |
| 2024-01-03 | N/A | Other | Other | 34,802 | N/A |
| 2023-06-20 | N/A | Other | Sell | 192,547 | 1,406,228.50 EUR |
| 2023-06-19 | N/A | Other | Sell | 30,661 | 209,629.26 EUR |
| 2023-06-16 | N/A | Other | Sell | 85,589 | 582,493.06 EUR |
| 2023-06-15 | N/A | Other | Sell | 28,179 | 189,503.78 EUR |
| 2023-06-14 | N/A | Other | Sell | 228,951 | 1,519,914.11 EUR |
| 2023-06-13 | N/A | Other | Sell | 29,401 | 187,922.37 EUR |
| 2023-06-12 | N/A | Other | Sell | 117,854 | 733,782.57 EUR |
| 2023-05-10 | N/A | Other | Buy | 87,523 | N/A |
Peer Companies
